You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-squamous NSCLC

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Lung Non-Small Cell Squamous Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage IIIB Lung Cancer

Active, not recruiting
  • Metastatic Lung Non-Small Cell Squamous Carcinoma
  • +7 more
  • Los Angeles, California
  • +9 more
Dec 17, 2022

Carcinoma, Squamous Cell of Head and Neck (HNSCC), Melanoma, NSCLC (NSCLC) Trial in Amsterdam (BI 765063, Ezabenlimab, [89Zr]Zr-

Recruiting
  • Carcinoma, Squamous Cell of Head and Neck (HNSCC)
  • +2 more
  • BI 765063
  • +4 more
  • Amsterdam, Netherlands
    Amsterdam UMC Locatie VUMC
Jan 9, 2023

Non Small Cell Lung Cancer Trial in France (Paclitaxel, Bevacizumab, Atezolizumab)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Amiens, France
  • +42 more
Mar 10, 2023

Non Small Cell Lung Cancer Metastatic Trial in Worldwide (TG4010, Chemotherapy, Nivolumab)

Completed
Has Results
  • Non Small Cell Lung Cancer Metastatic
  • TG4010
  • +2 more
  • Charlotte, North Carolina
  • +8 more
Dec 22, 2021

Non-Small Cell Squamous Lung Cancer, Brain Metastases Trial in Guangzhou (Tislelizumab, paclitaxel, Carboplatin)

Recruiting
  • Non-Small Cell Squamous Lung Cancer
  • Brain Metastases
  • Tislelizumab, paclitaxel, Carboplatin
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jan 12, 2022

Cervical/Supraclavicular Metastasis From Non-small-cell Lung

Recruiting
  • Lung Cancer Metastatic
  • Needle or forceps biopsy of cervical and/or supraclavicular lymph nodes
  • Needle, forceps or surgical biopsy of any lesion other than cervical and/or supraclavicular lymph nodes
  • Roma, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Jan 23, 2023

Advanced Cancer, Advanced Malignancies, Bladder Cancer Trial (AB598, Zimberelimab, Carboplatin)

Not yet recruiting
  • Advanced Cancer
  • +11 more
  • (no location specified)
May 26, 2023

Squamous NSCLC Trial in Jinan ("Envafolimab" and "Chemotherapy" and "Recombinant Human Endostatin")

Recruiting
  • Squamous Non-small Cell Lung Cancer
  • "Envafolimab" and "Chemotherapy" and "Recombinant Human Endostatin"
  • Jinan, Shandong, China
  • +1 more
Feb 14, 2022

NSCLC Trial in Philadelphia (Carboplatin, Paclitaxel, Ramucirumab)

Recruiting
  • Non-small Cell Lung Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 14, 2022

Advanced Head and Neck Squamous Cell Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma Trial in

Recruiting
  • Advanced Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Indianapolis, Indiana
  • +4 more
Aug 19, 2022

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in Tampa, Durham (MEM-288 Intratumoral Injection)

Recruiting
  • Solid Tumor
  • +9 more
  • MEM-288 Intratumoral Injection
  • Tampa, Florida
  • +1 more
Jun 27, 2022

Lung Cancer Non Small Cell, Head and Neck Squamous Cell Carcinoma, Urothelial Carcinoma Bladder Trial in Spain, United Kingdom,

Recruiting
  • Lung Cancer Non Small Cell
  • +2 more
  • IO102-IO103 in combination with pembrolizumab
  • Duarte, California
  • +18 more
Dec 15, 2022

Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC)

Not yet recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • +3 more
  • (no location specified)
Jul 24, 2022

NSCLC, Hepatocellular Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in New York (cemiplimab, Platinum Doublet)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Nov 24, 2021

NSCLC Trial in Goyang-Si (CA and Nivolumab)

Recruiting
  • Non-small Cell Lung Cancer
  • CA and Nivolumab
  • Goyang-Si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022

Metastatic NSCLC, Recurrent NSCLC, Advanced Non-Small Cell Squamous Lung Cancer Trial in Nanjing (Sintilimab + Anlotinib +

Recruiting
  • Metastatic NSCLC
  • +2 more
  • Sintilimab + Anlotinib + Pemetrexed + Cisplatin or Carboplatin
  • Sintilimab + Anlotinib + Albumin Paclitaxel + Carboplatin
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Aug 10, 2021

Lung Tumors Trial in Guangzhou (Sintilimab, Pemetrexed, Platinum)

Active, not recruiting
Has Results
  • Lung Neoplasms
  • Guangzhou, China
    Sun Yat-Sen University Cancer Center
Jan 27, 2021

Non Small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer, Urothelial Carcinoma Trial in Augusta (Cabozantinib,

Recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • Augusta, Georgia
    Augusta University Georgia Cancer Center
Mar 6, 2022

Nivolumab in Locally Advanced or Metastatic Non-Small Cell Lung

Recruiting
  • Non-Small Cell Lung Cancer
    • Athens, Greece
      Local Institution
    Aug 31, 2021

    NSCLC, Head and Neck Squamous Cell Carcinoma Trial in Israel, Japan, United States (ABBV-514, Pembrolizumab, Budigalimab)

    Recruiting
    • Non-Small Cell Lung Cancer
    • Head and Neck Squamous Cell Carcinoma
    • Fullerton, California
    • +13 more
    Jul 11, 2022

    Non-squamous NSCLC Trial in Worldwide (Tusamitamab ravtansine)

    Recruiting
    • Non-squamous Non-small Cell Lung Cancer
    • Tusamitamab ravtansine
    • Edegem, Belgium
    • +18 more
    Aug 3, 2022

    MRD Trial in China (Adjuvant treatment for MRD positivity)

    Recruiting
    • MRD
    • Adjuvant treatment for MRD positivity
    • Beijing, China
    • +15 more
    Sep 12, 2022

    NSCLC Trial in Guangzhou (Bevacizumab in Combination With Paclitaxel/Carboplatin, IBI305 in Combination with

    Completed
    Has Results
    • NSCLC
    • Bevacizumab in Combination With Paclitaxel/Carboplatin
    • IBI305 in Combination with Paclitaxel/Carboplatin
    • Guangzhou, Guangdong, China
      Cancer Center; Sun Yat sen University;
    Nov 12, 2020

    NSCLC Trial in Seoul (Atezolizumab(Tecentriq), Pemetrexed, Bevacizumab)

    Recruiting
    • Non-small Cell Lung Cancer
    • Seoul, Gangnamgu, Korea, Republic of
      Samsung Medical Center
    Dec 27, 2021

    Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

    Not yet recruiting
    • Solid Tumor, Adult
    • +15 more
    • A2B530
    • xT-Onco with HLA-LOH Assay
    • Duarte, California
    • +6 more
    Feb 10, 2023